openPR Logo
Press release

MRSA Drugs Market Over USD 3.1 Bn By 2022; Assert MRFR

12-28-2017 11:42 AM CET | Health & Medicine

Press release from: Market Research Future

Market research future published research report on global MRSA Drugs Market. The global MRSA Drugs Market is expected to grow at a CAGR over ~ 4.4 % from 2017 to 2023 .
Global MRSA Drugs Market is expected to reach USD 3.1 Billion by the end of the forecasted period from 2016 to 2022; it is confidently expected that this market has a bright future.
Most MRSA infections occur mostly to individuals who've been in hospitals or in other medicinal services facilities, for example, nursing homes and dialysis centers. When it occurs in these places, it's known as healthcare services related MRSA (HA-MRSA). HA-MRSA infection normally is related with obtrusive techniques or gadgets, for example, surgeries, intravenous tubing or fake joints
Another type of MRSA disease has happened in most healthy individuals. Methicillin-safe staphylococcus aureus (MRSA) contamination is caused by a type of staph microscopic organisms that is resistant to a number of anti-toxins which are used to treat ordinary staph infections.
Among these individuals who are diagnosed with MRSA (CA-MRSA), it ideally starts as an excruciating skin boil and spreads by skin-to-skin contact. People who are contaminated maximum are at-hazard populations which includes, secondary school wrestlers, child care workers and individuals who live in crowded places.
Methicillin-resistant Staphylococcus aureus (MRSA) is an antibiotic resistant strains of the pathogen. MRSA infections are classified as hospital-acquired (HA-MRSA) or community-acquired (CA-MRSA). MRSA causes infections such as skin infections, bone and joint infections, bacteremia, animal infections and others.
According to bulletin of the atomic scientists, about 10 million people in the US (3.6 percent of the population) are immune-compromised. The World Health Organization estimated that about 36.7 million people had HIV/AIDS worldwide in 2016. Thus, the rising immune-compromised population is expected to propel the market growth over the review period. Additionally, growing geriatric population projected to support the growth of the market since older people are more susceptible to MRSA infections. World Health Organization estimated that during 2015-2050, the proportion of the world's population will be nearly double from 12% to 22% and by 2020, the number of people aged over 60 years likely to outnumber children younger than 5 years.

Another strong driver is growing concerns of MRSA infections and increasing government support to curb MRSA. For example, hospital readmissions reduction program established under Affordable Care Act (ACA) financially penalizes hospitals if they have higher than expected 30-day readmission rates for diseases such as pneumonia. The recommendations of the committee has resulted in hospital readmissions national priority and a direct financial incentive to reduce readmissions. The financial incentives for reducing readmissions and the rising cost of non-compliance is expected to benefit the MRSA drugs market.
High cost of novel drug therapy and low healthcare expenditure in developing regions projected to hamper the growth of the market over the review period. Moreover, patent expiry is also expected to lower the market value due to generic competition. For example, Pfizer’s Zyvox and Merck’s Cubicin, used for the treatment of MRSA have lost patents in major markets and their patent for alternative formulations and chemical forms is threatened by imminent patent expiry dates, which is expected to lower the market due to competition from generics and greater market fragmentation.
Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/2102

Key Players for MRSA Drugs Market:
• Allergan, Plc
• Merck Inc
• Pfizer
• Savara Pharmaceuticals
• Sealife Pharma
• Sequella Inc
• Theravance Biopharma
• Baxter International
• AstraZeneca
• GSK
• Cempra Inc
• Biopharma AS
• Galapagos NV
• XBiotech
• NovaDigm Therapeutics Inc.
Regional Analysis of MRSA Drugs Market:
Globally North America is the largest market for MRSA Drugs; Europe is expected to be the second-largest market. Furthermore Asia Pacific market is expected to be the fastest growing market for MRSA Drugs.
Segments:
MRSA drugs market has been segmented on the basis of drug class which comprises of folate antagonist, lipopeptides, tetracycline, oxazolidinone, cephalosporin, and lipoglycopeptide. On the basis of drug origin the market is also segmented into semisynthetic drug, synthetic drugs and others.
Get Discount @ https://www.marketresearchfuture.com/check-discount/2102
The report for MRSA Drugs Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
Continue…
We are thankful for the support and assistance from MRSA Drugs Market Research Report- Global Forecast To 2022 chain related technical experts and marketing experts during Research Team survey and interviews.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MRSA Drugs Market Over USD 3.1 Bn By 2022; Assert MRFR here

News-ID: 878624 • Views:

More Releases from Market Research Future

Denim Market Size By 2035 with 5.25 USD Billion in 2025 to 132.4 USD Billion, Due To Due to increasing popularity of Denim jeans, Denim jackets, and other denim apparel.
Denim Market Size By 2035 with 5.25 USD Billion in 2025 to 132.4 USD Billion, Du …
Denim Market Size Grow at a 75.25 USD Billion in 2025 to 132.4 USD Billion by 2035, CAGR of 5.81% By 2025 - 2035 Global Denim Market is entering a new phase of transformation as consumer demand, fashion cycles, and sustainable innovation continue to reshape the industry. Denim, once considered a classic wardrobe staple, has evolved into a versatile, fashion-driven category supported by innovations in fabric technology, eco-friendly production, and shifting
Humanoid Robots Market Size to Reach USD 13.8 Billion by 2032, Growing at 50.2% CAGR from 2024
Humanoid Robots Market Size to Reach USD 13.8 Billion by 2032, Growing at 50.2% …
The global Humanoid Robots Market is projected to reach USD 13.8 Billion by 2032, growing at a robust CAGR of 50.2% during the forecast period from 2024 to 2032. Driven by advancements in artificial intelligence, machine learning, and machine vision, humanoid robots-designed with human-like characteristics-are witnessing widespread adoption across healthcare, education, space exploration, and service industries. These robots are enhancing operational efficiency, performing complex tasks, and improving customer engagement across multiple
Vertical Farming Market Expansion: USD 9.023 Billion in 2025 Growing to USD 58.83 Billion by 2035
Vertical Farming Market Expansion: USD 9.023 Billion in 2025 Growing to USD 58.8 …
The Vertical Farming Market was estimated at USD 7.48 Billion in 2024 and is projected to grow from USD 9.023 Billion in 2025 to USD 58.83 Billion by 2035, exhibiting a robust CAGR of 20.62% during the forecast period from 2025 to 2035. Driven by increasing demand for sustainable agriculture, urbanization, and technological advancements in controlled-environment farming, vertical farming solutions are seeing widespread adoption across commercial, industrial, and urban agriculture sectors. Key
Robotics Market Trends and Forecast: USD 74,120.70 Million in 2024 Expected to Hit USD 476,019.67 Million by 2035
Robotics Market Trends and Forecast: USD 74,120.70 Million in 2024 Expected to H …
The Robotics Market was valued at USD 74,120.70 Million in 2024 and is projected to reach USD 476,019.67 Million by 2035, growing at a robust CAGR of 18.4% during the forecast period from 2024 to 2035. Driven by advancements in medical robots, growing industrial robotics adoption, and the development of AI technologies, robotics solutions are witnessing widespread adoption across healthcare, manufacturing, logistics, and service sectors. Despite challenges like high initial costs

All 5 Releases


More Releases for MRSA

Mrsa Drugs Market Size, Share, Forecast Report 2025-2034
The MRSA Drugs Market Is Set To Grow At An Estimated CAGR Of 6.5% From 2025 To 2034, Rising From $6.8 Billion In 2024 To $11 Billion By 2034. On April 29, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Mrsa Drugs market goods. The market study excludes key regions that are accelerating marketization. This section
Combating MRSA with Cutting-Edge Pharmaceutical Advances
"The Business Research Company recently released a comprehensive report on the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The methicillin-resistant
MRSA Antibiotics Market Analysis, Size, Current Scenario and Future Prospects
MRSA Antibiotics Market was estimated at US$ billion in 2023 and is predicted to reach US$ billion by 2029 with sales revenue expected to register CAGR of 4.3% over the forecast period. Rising number of surgical conditions from chronic diseases such as diabetes, chronic respiratory and renal diseases are expected to increase the demand of post-operative MRSA anti-infective therapies. Important changes in the business allow key players to attain larger profits.
VRE and MRSA Antibiotic Market 2021 | Detailed Report
According to Market Study Report, VRE and MRSA Antibiotic Market provides a comprehensive analysis of the VRE and MRSA Antibiotic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of VRE and MRSA Antibiotic Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4645656 The
MRSA Testing Market Analysis of Top industry Scenario
Global MRSA Testing Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Global MRSA Testing Market by Type (Immunodiagnostics and Molecular Diagnostics) By
Find out Why MRSA Antibiotics Market Is Thriving Worldwide
A new market study on Global (United States, European Union and China) MRSA Antibiotics Market with 100+ market data Tables, Pie Chart & Graphs is released that will provide complete assessment of the Market and covers evolving trends, current scenario analysis and growth factors, and industry validated market data. The research study provides market breakdown by revenue and volume (if applicable) and price history estimates for Global (United States, European